Assessing cardiovascular risk in women: looking beyond traditional risk factors.

Assessing cardiovascular risk in women: looking beyond traditional risk factors.
复制标题

评估女性心血管风险:超越传统风险因素。

DOI:
10.1016/j.tcm.2014.10.024
复制
发表时间:
2015
影响因子:
9.3
通讯作者:
Pepine,CarlJ
Pepine,CarlJ
中科院分区:
医学2区
文献类型:
--
作者:
Park,KiE;Pepine,CarlJ

文献摘要

参考文献

被引文献

相似文献

尽管心血管疾病 (CVD) 仍然是女性发病和死亡的最普遍原因,但该人群的心血管风险和疾病往往未被及时识别。因此,许多心血管疾病高危女性从未接受过适当的预防策略,而这些策略已被证明可以降低心血管疾病和相关不良后果的风险。对此,Mehta等人的综述文章[1]对于认真推进女性医疗保健的临床医生来说,这是一本“必读”的书。显着的进展来自于纳内特·温格 (Nanette Wenger) 博士等该领域先驱者的不懈努力,以及女性健康倡议 (WHI)、心脏和雌激素/孕激素替代研究 (HERS)、女性缺血综合征评估 (WISE) 等里程碑式研究,以及其他对于强调女性特定 CVD 评估重要性至关重要的研究。正如 Wenger [2] 指出的那样,这项工作使该领域从 CVD 被认为是一种“男性疾病”发展到了一个更加开明的立场,即 CVD 现在也被认为是一种女性疾病,其中多种 CVD 疾病仍未得到充分认识和治疗。尽管在女性心血管疾病的识别和治疗方面取得了进展,但最不受关注的领域也许是风险评估。在 Mehta 等人的当前文章中[1],该领域的专家回顾了涉及女性风险因素评估的各种主题。它重点关注妇女特有的传统和非传统风险因素,并强调该领域内取得进展的领域以及需要进一步研究的领域。
Although cardiovascular disease (CVD) remains the most prevalent cause of morbidity and mortality among women, CV risk and disease in this population is often not recognized in a timely manner. As a result, many women at high risk for CVD never receive appropriate preventive strategies that have proven to reduce risk for CVD and related adverse outcomes. In this regard, the review article by Mehta et al.[1] is a “must read” for the clinician who is serious about advancing health care for women.Significant progress has come from the tireless work of pioneers in the field such as Dr. Nanette Wenger and landmark studies such as Women's Health Initiative (WHI), Heart and Estrogen/Progestin Replacement study (HERS), Women's Ischemic Syndrome Evaluation (WISE), and others that were crucial in highlighting the importance of specific CVD assessment in women. This body of work, as Wenger [2] notes, has advanced the field from CVD being thought of as a “man's disease” to a more enlightened position where CVD is now also recognized as a woman's disease in which a wide variety of CVD conditions remain under-appreciated and under-treated. Although advances have been made in identification and treatment of CVD among women, perhaps the area of least focus has been risk assessment. In the current article by Mehta et al.[1], experts in the field review a wide variety of topics addressing risk factor assessment in women. It provides an important focus on women-specific risk factors, both traditional and non-traditional, and highlights areas of progress within the field as well as areas in need of further study.
DOI: 10.1016/j.tcm.2014.10.005
发表时间: 2015-02
影响因子: 9.3
作者:
Mehta PK;Wei J;Wenger NK
通讯作者: Wenger NK
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者:
P. Ridker;J. Buring;N. Rifai;N. Cook
通讯作者: N. Cook
DOI: 10.1007/s11906-014-0475-3
发表时间: 2014-09-01
影响因子: 5.6
作者:
Herrera-Garcia, Guadalupe;Contag, Stephen
通讯作者: Contag, Stephen